Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial.

Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2006-

Attitude of Health Personnel* ; Communication* ; Health Knowledge, Attitudes, Practice* ; Physician-Patient Relations*; Complementary Therapies/*education ; Education, Medical, Continuing/*methods ; Integrative Medicine/*education ; Neoplasms/*therapy ; Oncologists/*education; Computer-Assisted Instruction ; Curriculum ; Germany ; Humans ; Learning ; Multicenter Studies as Topic ; Neoplasms/diagnosis ; Neoplasms/psychology ; Patient Education as Topic ; Patient Participation ; Prospective Studies ; Randomized Controlled Trials as Topic

Background: Many cancer patients are interested in complementary and integrative medicine during and after regular cancer treatment. Given the high number of users it is important that physicians and patients engage in a dialog about useful complementary and integrative medicine therapies during cancer treatment. In a prospective, multi-center, cluster-randomized evaluation study we will develop, implement and evaluate a training program for oncology physicians advising their patients on complementary and integrative medicine. The main objective of the study is to evaluate whether training physicians in a blended-learning approach (e-learning + skills-training workshop) in providing advice to their cancer patients on complementary and integrative medicine, in addition to handing out an information leaflet about reputable websites, has different effects on the outcomes of patients, physicians, and their interaction level, compared to only giving out the information leaflet.
Methods/design: Forty-eight oncology physicians will be included into a cluster-randomized trial to either participate or not in the blended-learning training. Physicians will then advise 10 cancer patients each, resulting in 480 patients participating in the trial. The blended learning consists of nine units of up to 45 min of e-learning and 18 units of up to 45 min of on-site skills-training workshop focusing. Outcomes will be measured on the physician, patient, and physician-patient-interaction level.
Discussion: A blended-learning program for oncology physicians to advise their cancer patients in a systematic way and a reasonable time frame on complementary and integrative medicine will be evaluated in depth in a large cluster-randomized trial.
Trial Registration: German Clinical Trials Register, ID: DRKS00012704 . Registered on 28 August 2017.

Arch Intern Med. 2002 May 27;162(10):1176-81. (PMID: 12020190)
Complement Ther Med. 2004 Jun-Sep;12(2-3):90-8. (PMID: 15561518)
Ann Oncol. 2005 Apr;16(4):655-63. (PMID: 15699021)
Pharm World Sci. 2005 Apr;27(2):96-103. (PMID: 15999919)
BMC Complement Altern Med. 2006 Dec 07;6:40. (PMID: 17156416)
Ann Oncol. 2007 Mar;18(3):479-84. (PMID: 17272832)
Psychother Psychosom Med Psychol. 2008 Jan;58(1):5-15. (PMID: 17429761)
BMC Complement Altern Med. 2007 Aug 04;7:25. (PMID: 17683580)
Health (London). 2008 Apr;12(2):139-55. (PMID: 18400826)
Patient Educ Couns. 2010 Jan;78(1):130-3. (PMID: 19560303)
Patient Educ Couns. 2010 May;79(2):143-51. (PMID: 19783116)
Integr Cancer Ther. 2010 Jun;9(2):168-76. (PMID: 20462858)
Integr Cancer Ther. 2012 Sep;11(3):187-203. (PMID: 22019489)
Eur J Cancer. 2012 Nov;48(17):3133-9. (PMID: 22633625)
J Altern Complement Med. 2014 Jan;20(1):12-8. (PMID: 23863085)
Cancer Nurs. 2015 Mar-Apr;38(2):E10-26. (PMID: 25692736)
Cancer Clin Oncol. 2013 Nov;2(2):81-92. (PMID: 26640610)
Support Care Cancer. 2016 Sep;24(9):3857-62. (PMID: 27075675)
Patient Educ Couns. 2016 Nov;99(11):1858-1864. (PMID: 27345253)
Integr Cancer Ther. 2018 Jun;17(2):380-387. (PMID: 27585628)
BMC Cancer. 2016 Nov 4;16(1):843. (PMID: 27809814)
PLoS One. 2016 Nov 3;11(11):e0165801. (PMID: 27812163)
Support Care Cancer. 2017 May;25(5):1485-1494. (PMID: 28025709)
Complement Ther Med. 2017 Aug;33:78-84. (PMID: 28735830)

109863 German Cancer Aid

Keywords: Adverse effects; Blended learning; Cancer; Communication; Complementary medicine; Integrative medicine

Date Created: 20190131 Date Completed: 20190528 Latest Revision: 20200225

20221213

PMC6352447

10.1186/s13063-019-3193-y

30696465